GABA transporter-1 inhibitor NO-711 alters the EEG power spectra and enhances non-rapid eye movement sleep during the active phase in mice

European Neuropsychopharmacology

Volumn 24, Issue 4, 2014, Pages 585-594

  Xu, Xin Hong ^a   Qiu, Mei Hong ^a   Dong, Hui ^a   Qu, Wei Min ^a   Urade, Yoshihiro ^b   Huang, Zhi Li ^a  

^a FUDAN UNIVERSITY   (China)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

C Fos; EEG power density; GABA transport subtype 1; NO 711; Sleep

Indexed keywords

1 [2 (BENZHYDRYLIDENEAMINOOXY)ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; GABA TRANSPORTER 1; PROTEIN C FOS; ZOLPIDEM; 4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID UPTAKE INHIBITOR; HYPNOTIC SEDATIVE AGENT; NERVE PROTEIN; NIPECOTIC ACID DERIVATIVE; OXIME; SLC6A1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; FREQUENCY MODULATION; LATERAL HYPOTHALAMUS; MALE; MEDIAL PREOPTIC AREA; MOUSE; NONHUMAN; NONREM SLEEP; POWER SPECTRUM; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REM SLEEP; SLEEP; SLEEP QUALITY; SLEEP WAKING CYCLE; TUBEROMAMMILLARY NUCLEUS; VENTROLATERAL PREOPTIC AREA; WAKEFULNESS; ELECTROMYOGRAM; EPILEPSY; LATENT PERIOD; LOW DRUG DOSE; MEDIAN PREOPTIC NUCLEUS; PREOPTIC NUCLEUS; THALAMUS VENTRAL NUCLEUS; VENTROLATERAL PREOPTIC NUCLEUS; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; AROUSAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; NERVE CELL; SLEEP STAGE;

ANIMALS; AROUSAL; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GABA UPTAKE INHIBITORS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURONS; NIPECOTIC ACIDS; ORGAN SPECIFICITY; OXIMES; PREOPTIC AREA; PROTO-ONCOGENE PROTEINS C-FOS; SLEEP STAGES;

EID: 84895862969     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.09.002     Document Type: Article

References (34)

1. Borden L.A., Murali Dhar T.G., Smith K.E., Weinshank R.L., Branchek T.A., Gluchowski C. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur. J. Pharmacol. 1994, 269:219-224.
2. Brodie M.J. Tiagabine pharmacology in profile. Epilepsia 1995, 36(Suppl. 6):S7-S9.
3. Chen C.R., Tan R., Qu W.M., Wu Z., Wang Y., Urade Y., Huang Z.L. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice. Br. J. Pharmacol. 2011, 164:1534-1546.
4. Chiu C.S., Jensen K., Sokolova I., Wang D., Li M., Deshpande P., Davidson N., Mody I., Quick M.W., Quake S.R., Lester H.A. Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions. J. Neurosci. 2002, 22:10251-10266.
5. Conti F., Minelli A., Melone M. GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res. Brain Res. Rev. 2004, 45:196-212.
6. Ebert B., Wafford K.A., Deacon S. Treating insomnia: current and investigational pharmacological approaches. Pharmacol. Ther. 2006, 112:612-629.
7. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
8. Guastella J., Nelson N., Nelson H., Czyzyk L., Keynan S., Miedel M.C., Davidson N., Lester H.A., Kanner B.I. Cloning and expression of a rat brain GABA transporter. Science 1990, 249:1303-1306.
9. Hambrecht-Wiedbusch V.S., Gauthier E.A., Baghdoyan H.A., Lydic R. Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation. Sleep 2010, 33:909-918.
10. Hong Z.Y., Huang Z.L., Qu W.M., Eguchi N., Urade Y., Hayaishi O. An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J. Neurochem. 2005, 92:1542-1549.
11. Huang Z.L., Qu W.M., Eguchi N., Chen J.F., Schwarzschild M.A., Fredholm B.B., Urade Y., Hayaishi O. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat. Neurosci. 2005, 8:858-859.
12. Huang Z.L., Qu W.M., Li W.D., Mochizuki T., Eguchi N., Watanabe T., Urade Y., Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. USA 2001, 98:9965-9970.
13. Jensen K., Chiu C.S., Sokolova I., Lester H.A., Mody I. GABA transporter-1 (GAT1)-deficient mice: differential tonic activation of GABAA versus GABAB receptors in the hippocampus. J. Neurophysiol. 2003, 90:2690-2701.
14. Lancel M., Faulhaber J., Deisz R.A. Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat. Br. J. Pharmacol. 1998, 123:1471-1477.
15. Leach J.P., Brodie M.J. Tiagabine. Lancet 1998, 351:203-207.
16. Liu Z., Xu X.H., Liu T.Y., Hong Z.Y., Urade Y., Huang Z.L., Qu W.M. Safranal enhances non-rapid eye movement sleep in pentobarbital-treated mice. CNS Neurosci. Ther. 2012, 18:623-630.
17. Madsen K.K., White H.S., Schousboe A. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs. Pharmacol. Ther. 2010, 125:394-401.
18. Mathias S., Wetter T.C., Steiger A., Lancel M. The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects. Neurobiol. Aging 2001, 22:247-253.
19. McGinty D., Szymusiak R. Brain structures and mechanisms involved in the generation of NREM sleep: focus on the preoptic hypothalamus. Sleep Med. Rev. 2001, 5:323-342.
20. Nitz D., Siegel J.M. GABA release in posterior hypothalamus across sleep-wake cycle. Am. J. Physiol. 1996, 271:R1707-1712.
21. Paredes R.G., Agmo A. GABA and behavior: the role of receptor subtypes. Neurosci. Biobehav. Rev. 1992, 16:145-170.
22. Qiu M.H., Qu W.M., Xu X.H., Yan M.M., Urade Y., Huang Z.L. D(1)/D(2) receptor-targeting l-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice. Pharmacol. Biochem. Behav. 2009, 94:16-23.
23. Qu W.M., Huang Z.L., Xu X.H., Aritake K., Eguchi N., Nambu F., Narumiya S., Urade Y., Hayaishi O. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc. Natl. Acad. Sci. USA 2006, 103:17949-17954.
24. Qu W.M., Xu X.H., Yan M.M., Wang Y.Q., Urade Y., Huang Z.L. Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J. Neurosci. 2010, 30:4382-4389.
25. Sagar S.M., Sharp F.R., Curran T. Expression of c-Fos protein in brain: metabolic mapping at the cellular level. Science 1988, 240:1328-1331.
26. Saper, C.B., Fuller, P.M., Pedersen, N.P., Lu, J., Scammell, T.E., 2010. Sleep state switching. Neuron 68, 1023-1042.
27. Schachter S.C. A review of the antiepileptic drug tiagabine. Clin. Neuropharmacol. 1999, 22:312-317.
28. Sherin J.E., Shiromani P.J., McCarley R.W., Saper C.B. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271:216-219.
29. Suzdak P.D., Frederiksen K., Andersen K.E., Sorensen P.O., Knutsen L.J., Nielsen E.B. NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization. Eur. J. Pharmacol. 1992, 224:189-198.
30. Tobler I., Kopp C., Deboer T., Rudolph U. Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype. Proc. Natl. Acad. Sci. USA 2001, 98:6464-6469.
31. Vienne J., Bettler B., Franken P., Tafti M. Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric acid, and Baclofen on EEG activity and sleep regulation. J. Neurosci. 2010, 30:14194-14204.
32. Wafford K.A., Ebert B. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nat. Rev. Drug. Discov. 2008, 7:530-540.
33. Xu, Qu, Bian, Huang, Fei, Urade and Huang, Essential roles of GABA transporter-1 in controlling rapid eye movement sleep and in increased slow wave activity after sleep deprivation, PLoS One, (in press).
34. Yan M.M., Xu X.H., Huang Z.L., Yao M.H., Urade Y., QU W.M. Selection of optimal epoch duration in assessment of rodent sleep-wake profiles. Sleep Biol. Rhythms 2011, 9:46-55.